Wenting Liao

13PUBLICATIONS
93CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsNanometrologyPredictive and prognostic markersMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Feb 22, 2025
Macrocarpal I induces immunogenic cell death and synergizes with immune checkpoint inhibition by targeting tubulin and PARP1 in colorectal cancer.

Yaxin Zhang, Huali Li, Yali Zhao

|Jan 25, 2025
A novel USP4 inhibitor that suppresses colorectal cancer stemness by promoting β-catenin and Twist1 degradation.

Fengtian Li, Yi Zhou, Xinyue Lin

|Nov 06, 2024
NAT10-mediated mRNA N4-acetylcytidine reprograms serine metabolism to drive leukaemogenesis and stemness in acute myeloid leukaemia.

Subo Zhang, Feng Huang, Yushuai Wang

|Oct 04, 2024
Oncogenic KRAS drives immunosuppression of colorectal cancer by impairing DDX60-mediated dsRNA accumulation and viral mimicry.

Yi Zhou, Yaxin Zhang, Mingzhou Li

|Mar 04, 2024
Combined anti-PD-1, HDAC inhibitor and anti-VEGF for MSS/pMMR colorectal cancer: a randomized phase 2 trial.

Feng Wang, Ying Jin, Min Wang

|Dec 08, 2023
LncRNA MIR200CHG inhibits EMT in gastric cancer by stabilizing miR-200c from target-directed miRNA degradation.

Yixiao Zhu, Chengmei Huang, Chao Zhang

Pageof 3

Frequent Collaborators

3 joint publications

Huilin Huang

3 joint publications

Libing Song

2 joint publications

Guozhen Liu

2 joint publications

Fengtian Li